SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001140361-21-005021
Filing Date
2021-02-16
Accepted
2021-02-16 16:42:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10020422_sc13ga.htm SC 13G/A 58621
  Complete submission text file 0001140361-21-005021.txt   60202
Mailing Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102
Business Address 1001 10TH AVENUE SOUTH SUITE 216 NAPLES FL 34102 239-384-9750
Pentwater Capital Management LP (Filed by) CIK: 0001425851 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Subject) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87536 | Film No.: 21639818
SIC: 2834 Pharmaceutical Preparations